Persistence of Vaccine‐Derived Polioviruses among Immunodeficient Persons with Vaccine‐Associated Paralytic Poliomyelitis
Citations Over TimeTop 10% of 2003 papers
Abstract
To estimate long-term poliovaccine virus persistence among immunodeficient patients with vaccine-associated paralytic poliomyelitis (iVAPP), cases reported in the United States during 1975-1997 were reviewed, with subsequent follow-up and virological testing. Six (16.2%) of 37 subjects excreted poliovaccine viruses for > or =6 months. Partial genomic sequencing of their available poliovirus isolates showed considerable divergence from the prototype Sabin strain in all cases. Poliovirus persistence declined over time since the last oral poliovaccine dose: at 6 months, 19.4%; 1 year, 14.3%; 5 years, 4%; and 10 years, 0% (P<.05) of patients. Despite the high prevalence of poliovaccine virus persistence among patients with iVAPP, this group appears to be an unlikely source of poliovirus reintroduction in developed countries because of the rarity and high fatality rate of iVAPP and the possible spontaneous clearance of polioviruses. These results are important for developing "endgame" strategies for the Global Poliomyelitis Eradication Program.
Related Papers
- → Seroimmunity to poliomyelitis in an Albanian immigrant population(1992)23 cited
- [The role of epidemiologic surveillance of migrants in the system of poliomyelitis control].(2013)
- → The Mechanism of Poliovirus Eradication(2014)12 cited
- → An Etiologic Study of Clinical Paralytic Poliomyelitis(1961)21 cited
- Polio antibody outfit of newborns and infants born after 20 years of mass vaccination with live poliovaccine.(1984)